Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model

被引：0
|
作者：
Christian Linke
Markus Wösle
Anja Harder
机构：
[1] joint Faculty of the Brandenburg University of Technology Cottbus – Senftenberg,Faculty of Health Sciences
[2] the Brandenburg Medical School Theodor Fontane and the University of Potsdam,Clinic for Radiotherapy and Radiation Oncology
[3] Dessau City Hospital,Institute of Neuropathology
[4] University Hospital Münster,Institute of Pathology
[5] Brandenburg Medical School Theodor Fontane,undefined
[6] Dessau City Hospital,undefined
来源：
BMC Cancer | / 20卷
关键词：
MPNST; NF1; 3-BrPA; Glycolysis; Mitochondrial respiration; p53; Starvation; Cell cycle; PA28; B8 fibroblasts;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model
    Linke, Christian
    Woesle, Markus
    Harder, Anja
    BMC CANCER, 2020, 20 (01)
  • [2] Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate
    Lis, Pawel
    Jurkiewicz, Pawel
    Cal-Bakowska, Magdalena
    Ko, Young H.
    Pedersen, Peter L.
    Goffeau, Andre
    Ulaszewski, Stanislaw
    ONCOTARGET, 2016, 7 (09) : 10153 - 10173
  • [3] 3-Bromopyruvate (3BP) Inhibits Growth of Thyroid Cancer Cells in Vitro and in Vivo
    Lv, Hongjun
    Fu, Jiao
    Ji, Meiju
    Hou, Peng
    Shi, Bingyin
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [4] 3-Bromopyruvate in combination with radiation inhibits pancreatic cancer growth by dismantling mitochondria and ATP generation in a preclinical mouse model.
    Roy, Sanjit K.
    Dukic, Tijana
    Bhandary, Binny
    Acharya, Aneesh
    Tu, Kevin J.
    Ko, Young H.
    Shukla, Hem D.
    CANCER RESEARCH, 2022, 82 (12)
  • [5] 3-Bromopyruvate inhibits pancreatic tumor growth by stalling glycolysis, and dismantling mitochondria in a syngeneic mouse model
    Roy, Sanjit
    Dukic, Tijana
    Bhandary, Binny
    Tu, Kevin J.
    Molitoris, Jason
    Ko, Young H.
    Shukla, Hem D.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 4977 - +
  • [6] A mathematical model for the in vitro kinetics of the anti-cancer agent topotecan
    Evans, ND
    Errington, RJ
    Shelley, M
    Feeney, GP
    Chapman, MJ
    Godfrey, KR
    Smith, PJ
    Chappell, MJ
    MATHEMATICAL BIOSCIENCES, 2004, 189 (02) : 185 - 217
  • [7] 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
    Peter L. Pedersen
    Journal of Bioenergetics and Biomembranes, 2012, 44 : 1 - 6
  • [8] Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer
    Buijs, Manon
    Vossen, Josephina A.
    Geschwind, Jean-Francois H.
    Ishimori, Takayoshi
    Engles, James M.
    Acha-Ngwodo, Obele
    Wahl, Richard L.
    Vali, Mustafa
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 120 - 123
  • [9] Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer
    Manon Buijs
    Josephina A. Vossen
    Jean-Francois H. Geschwind
    Takayoshi Ishimori
    James M. Engles
    Obele Acha-Ngwodo
    Richard L. Wahl
    Mustafa Vali
    Investigational New Drugs, 2009, 27
  • [10] 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue
    Pedersen, Peter L.
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2012, 44 (01) : 1 - 6
12345